Quick Answer
NovoCure Ltd reported Total Revenue of $655.35 million for fiscal year 2025.
NovoCure Ltd Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $655.35M | +8.3% |
| 2024 | $605.22M | +18.8% |
| 2023 | $509.34M | -5.3% |
| 2022 | $537.84M | +0.5% |
| 2021 | $535.03M | +8.2% |
| 2020 | $494.37M | +40.7% |
| 2019 | $351.32M | +41.6% |
| 2018 | $248.07M | +40.1% |
| 2017 | $177.03M | +113.6% |
| 2016 | $82.89M | +150.5% |
| 2015 | $33.09M | +113.6% |
| 2014 | $15.49M | +49.5% |
| 2013 | $10.36M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $167.20M | +7.8% | +5.3% |
| June 30, 2025 | $158.81M | +5.6% | +2.5% |
| March 31, 2025 | $154.99M | +11.9% | -0.1% |
| September 30, 2024 | $155.09M | +21.8% | +3.2% |
| June 30, 2024 | $150.36M | +19.3% | +8.6% |
| March 31, 2024 | $138.50M | +13.4% | +8.8% |
| September 30, 2023 | $127.32M | -2.8% | +1.0% |
| June 30, 2023 | $126.05M | -10.5% | +3.2% |
- NovoCure Ltd showed an increase of +8.3% in Total Revenue compared to the prior fiscal year.
- Over the 2013–2025 period, NovoCure Ltd’s total revenue has grown by 6226.4% (from $10.36 million to $655.35 million).
- The most recent figure is from NovoCure Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: